Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stroke Global-2026

About Conference


The 10th International Conference on Neurological Disorders and Stroke is a premier international forum dedicated to advancing research, innovation, clinical practice, and professional collaboration in the fields of neurology, neuroscience, cerebrovascular medicine, and stroke care. Scheduled to be held on December 16–17, 2026, in Paris, France, this international gathering will bring together distinguished neurologists, neurosurgeons, stroke specialists, neuroscientists, researchers, rehabilitation professionals, healthcare practitioners, policymakers, educators, and students from across the globe.

Under the theme “Innovations in Neurology and Stroke Care: Advancing Prevention, Precision Diagnosis, Treatment and Brain Recovery,” the conference aims to promote scientific excellence, interdisciplinary collaboration, and innovative approaches to the prevention, diagnosis, treatment, and management of neurological disorders and stroke. The event will provide a dynamic platform for discussing emerging challenges, breakthrough research, advanced therapeutic strategies, and evidence-based approaches designed to improve neurological health and patient outcomes.

Participants will have the opportunity to engage in keynote presentations, plenary lectures, scientific sessions, oral and poster presentations, panel discussions, workshops, and interactive networking activities led by internationally recognized experts. The scientific program will explore a broad range of topics, including stroke prevention and management, acute ischemic and hemorrhagic stroke, neurointerventional procedures, neuroimaging, neurocritical care, neurodegenerative disorders, Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, neuroimmunology, neurogenetics, pediatric neurology, cognitive neurology, brain injury, and neurological rehabilitation.

The conference will also highlight emerging innovations transforming modern neurological care, including artificial intelligence in neurology, machine learning, precision medicine, digital health, advanced neuroimaging, biomarkers, brain-computer interfaces, neurotechnology, robotic rehabilitation, and data-driven approaches to neurological diagnosis and treatment. Special emphasis will be placed on multidisciplinary strategies for stroke recovery, cognitive rehabilitation, prevention of neurological disability, and improving long-term quality of life.

The conference offers an excellent opportunity for participants to establish international collaborations, develop research partnerships, exchange knowledge with global experts, and explore emerging trends in neurological and cerebrovascular medicine. Through meaningful scientific discussions, knowledge exchange, and professional networking, the 10th International Conference on Neurological Disorders and Stroke aims to inspire new research, strengthen global cooperation, encourage clinical innovation, and contribute to the advancement of better brain health, improved stroke outcomes, and the future of neurological care worldwide.

Sessions & Tracks

Track 1: Advances in Clinical Neurology

Contemporary approaches to neurological diagnosis and patient management, integrating clinical assessment, neurophysiology, advanced diagnostics, therapeutic decision-making, multidisciplinary care, and emerging clinical practices. Discussions will highlight complex neurological conditions, evolving treatment strategies, evidence-based approaches, and the translation of neurological discoveries into improved patient outcomes.

Track 2: Stroke Prevention, Risk Management & Brain Health

Innovative strategies for reducing stroke incidence through early risk identification, vascular health management, lifestyle modification, cardiovascular disease control, preventive medicine, patient education, and long-term monitoring. The program will also address secondary stroke prevention, recurrent stroke risk, healthy brain aging, and population-based approaches to improving cerebrovascular health.

Track 3: Acute Ischemic Stroke & Emergency Stroke Care

Rapid diagnosis and treatment of acute ischemic stroke, with emphasis on advanced imaging, reperfusion strategies, thrombolytic therapies, mechanical thrombectomy, large-vessel occlusion management, streamlined stroke pathways, tele-stroke services, emergency response systems, and multidisciplinary coordination to improve treatment times and neurological outcomes.

Track 4: Hemorrhagic Stroke & Cerebrovascular Disorders

Current approaches to intracerebral hemorrhage, subarachnoid hemorrhage, cerebral aneurysms, vascular malformations, cerebral venous disorders, and other cerebrovascular conditions, including early diagnosis, neurocritical management, surgical and endovascular interventions, prevention of secondary complications, and long-term neurological recovery.

Track 5: Neurointervention & Endovascular Neurology

Recent developments in minimally invasive cerebrovascular treatment, including advanced endovascular techniques, mechanical thrombectomy, aneurysm management, vascular device innovation, image-guided procedures, patient selection, procedural safety, treatment outcomes, and emerging technologies shaping the future of interventional neurology.

Track 6: Neurocritical Care & Neurological Emergencies

Advanced management of critically ill neurological patients requiring intensive monitoring and specialized intervention, covering severe stroke, brain edema, intracranial pressure, coma, status epilepticus, acute brain injury, neurological deterioration, cerebral protection, neuroprognostication, and coordinated neuro-intensive care.

Track 7: Neurodegenerative Diseases & Healthy Brain Aging

Recent advances in Alzheimer's disease, Parkinson's disease, dementia, Huntington's disease, motor neuron disorders, and other neurodegenerative conditions, with emphasis on disease mechanisms, early detection, biomarkers, neuroimaging, therapeutic development, cognitive preservation, disease progression, supportive care, and strategies for promoting healthy brain aging.

Track 8: Epilepsy, Seizure Disorders & Neurophysiology

Modern approaches to epilepsy and seizure disorders, including advanced diagnostic evaluation, EEG and neurophysiological monitoring, drug-resistant epilepsy, epilepsy surgery, seizure classification, emerging therapies, neurostimulation, pediatric epilepsy, personalized treatment, and strategies for improving long-term quality of life.

Track 9: Multiple Sclerosis, Neuroimmunology & Neuroinflammation

Emerging developments in multiple sclerosis and immune-mediated neurological disorders, focusing on disease mechanisms, neuroinflammatory pathways, biomarkers, advanced imaging, immunotherapies, disease-modifying treatments, autoimmune neurological conditions, personalized therapeutic strategies, and long-term disease monitoring.

Track 10: Pediatric Neurology & Neurodevelopmental Disorders

Innovative approaches to neurological care across infancy, childhood, and adolescence, including pediatric stroke, epilepsy, cerebral palsy, developmental disorders, congenital neurological conditions, genetic diseases, neonatal neurological injury, developmental delay, early diagnosis, family-centred care, and multidisciplinary interventions supporting lifelong neurological health.

Track 11: Neurotrauma, Brain Injury & Spinal Disorders

Advances in the prevention, diagnosis, acute management, surgical care, rehabilitation, and long-term recovery of traumatic brain and spinal injuries, with emphasis on neuroprotection, intracranial pressure management, concussion, cognitive impairment, spinal cord injury, neuroplasticity, functional restoration, and technologies supporting neurological recovery.

Track 12: Neuroimaging & Precision Diagnosis

Innovative applications of MRI, CT, PET, functional imaging, vascular imaging, molecular imaging, imaging biomarkers, and computational analysis for improving neurological diagnosis and treatment planning. Integration of advanced imaging with artificial intelligence, clinical data, and precision medicine will support earlier detection and more individualized neurological care.

Track 13: Artificial Intelligence, Digital Neurology & Neurotechnology

Applications of artificial intelligence, machine learning, predictive analytics, digital health, tele-neurology, wearable technologies, automated imaging analysis, clinical decision-support systems, brain-computer interfaces, and computational neuroscience in neurological research and clinical practice, alongside responsible innovation, data security, ethics, and patient-centred technology adoption.

Track 14: Neurorehabilitation, Neuroplasticity & Brain Recovery

Modern approaches to neurological rehabilitation following stroke, brain injury, and neurological disease, incorporating physical therapy, occupational therapy, speech and language rehabilitation, cognitive recovery, psychological support, neuroplasticity-based interventions, robotics, virtual reality, assistive technologies, digital rehabilitation, and personalized recovery programs.

Track 15: Neurogenetics, Biomarkers & Precision Medicine

Advances in genetic and molecular approaches to neurological disorders, including genomic medicine, inherited neurological diseases, molecular biomarkers, pharmacogenomics, proteomics, personalized treatment strategies, disease prediction, therapeutic response monitoring, and the translation of genetic and biomarker discoveries into clinically meaningful neurological care.

Track 16: Headache, Pain & Movement Disorders

Current developments in the diagnosis and treatment of migraine, cluster headache, chronic headache, neuropathic pain, Parkinsonian disorders, tremor, dystonia, ataxia, and other movement-related neurological conditions, with attention to disease mechanisms, personalized therapies, neuromodulation, multidisciplinary management, and emerging treatment technologies.

Track 17: Neuroinfectious Diseases & Emerging Neurological Conditions

Emerging developments in infections and conditions affecting the central and peripheral nervous systems, including meningitis, encephalitis, neuroviral diseases, neuroparasitic disorders, post-infectious neurological syndromes, neurological complications of emerging infections, diagnostic challenges, prevention strategies, and global approaches to neurological disease surveillance.

Track 18: Cognitive, Behavioral & Neuropsychiatric Neurology

Advances in cognitive and behavioral aspects of neurological disease, including memory disorders, post-stroke cognitive impairment, neuropsychiatric complications, behavioral changes, depression, anxiety, dementia-related challenges, and psychological recovery. Integrated approaches addressing cognitive, emotional, social, and functional needs will support comprehensive neurological care.

Track 19: Regenerative Neurology & Emerging Therapeutic Approaches

Innovative strategies for neural repair and restoration, including stem cell research, gene therapy, cellular therapies, tissue engineering, neurostimulation, neural regeneration, neuroprotective strategies, novel drug delivery systems, and emerging therapeutic technologies aimed at restoring neurological function and improving outcomes in currently difficult-to-treat disorders.

Track 20: Translational Neuroscience & Future Directions in Neurology

Integration of basic neuroscience discoveries with clinical research and patient care through innovative clinical trials, therapeutic development, biomarkers, precision medicine, digital health, artificial intelligence, neurotechnology, regenerative medicine, and collaborative research. The focus will be on accelerating scientific discoveries toward practical applications that can transform the future of neurological and stroke care.

Target Audience

The 10th International Conference on Neurological Disorders and Stroke is designed for a diverse international audience of professionals, researchers, academics, and organizations involved in neurology, stroke care, neuroscience, neurotechnology, and rehabilitation. The conference welcomes:

 

Market Analysis

The global market for neurological and stroke research, healthcare, diagnostics, therapeutics, rehabilitation, and related technologies represents a significant and expanding area of opportunity for scientific conferences. Neurological conditions affect more than 3 billion people worldwide, while WHO identifies neurological conditions as a leading cause of ill health and disability globally. Stroke remains one of the most significant neurological and cerebrovascular challenges, with approximately 11.9 million new strokes and 93.8 million people living with stroke globally in 2021.

The increasing burden of neurological disorders is creating strong demand for advances in prevention, early diagnosis, treatment, rehabilitation, and long-term patient management. The World Stroke Organization reports that the global burden of stroke has increased substantially over recent decades, with the estimated annual economic cost of stroke exceeding US$890 billion. The majority of stroke-related deaths and disability occur in low- and middle-income countries, creating significant opportunities for research collaboration, capacity building, healthcare innovation, and knowledge exchange.

A major growth area within the neurological healthcare landscape is the adoption of advanced technologies. Artificial intelligence, machine learning, digital health, tele-neurology, advanced neuroimaging, biomarkers, neurointerventional devices, brain-computer interfaces, robotics, and technology-assisted rehabilitation are increasingly influencing neurological research and clinical practice. Major scientific meetings are similarly expanding their programs around AI, brain health, stroke recovery, advanced diagnostics, and emerging interventions, demonstrating strong professional interest in these areas. 

The conference therefore has a broad and multidisciplinary market, attracting neurologists, neurosurgeons, stroke specialists, neuroscientists, neurointerventionalists, radiologists, rehabilitation professionals, researchers, academicians, healthcare institutions, pharmaceutical companies, biotechnology companies, medical-device manufacturers, digital-health organizations, and technology innovators. Its focus on the theme “Innovations in Neurology and Stroke Care: Advancing Prevention, Precision Diagnosis, Treatment and Brain Recovery” provides an opportunity to connect established neurological science with rapidly developing areas such as precision medicine, AI, neurotechnology, regenerative medicine, and personalized rehabilitation.

To Collaborate Scientific Professionals around the World

Conference Date December 16-17, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Stroke Research & Therapy Research & Reviews: Neuroscience

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Acute Ischemic Stroke
  • Advanced Neuroimaging
  • Advances In Clinical Neurology
  • Alzheimer?s Disease And Dementia
  • Artificial Intelligence In Neurology
  • Big Data And Machine Learning In Neurology
  • Brain Tumors And Neuro-Oncology
  • Cerebral Aneurysms And Vascular Malformations
  • Cerebral Venous Thrombosis
  • Cerebrovascular Disorders
  • Clinical Neurophysiology
  • Clinical Trials And Translational Neuroscience
  • Cognitive Rehabilitation
  • Depression And Mental Health After Stroke
  • Digital Biomarkers And Remote Neurological Monitoring
  • Digital Neurology And Telemedicine
  • Drug Discovery In Neurological Disorders
  • Epilepsy And Seizure Disorders
  • Future Directions And Innovations In Neurology And Stroke Care
  • Gene Therapy For Neurological Diseases
  • Geriatric Neurology And Brain Aging
  • Global Neurological Health And Disease Prevention
  • Headache And Migraine Disorders
  • Hemorrhagic Stroke
  • Mechanical Thrombectomy
  • Meningitis And Encephalitis
  • Moyamoya Disease And Rare Cerebrovascular Disorders
  • Multiple Sclerosis
  • Neurocritical Care
  • Neurodegenerative Diseases
  • Neurogenetics And Genomic Neurology
  • Neuroimaging In Stroke Diagnosis
  • Neuroimmunology And Neuroinflammation
  • Neuroinfectious Diseases
  • Neurointerventional Procedures
  • Neurological Biomarkers
  • Neurological Emergencies
  • Neuropathic Pain And Chronic Neurological Pain
  • Neuropharmacology And Emerging Therapies
  • Neuroplasticity And Brain Repair
  • Neuropsychiatry And Behavioral Neurology
  • Neurorehabilitation And Stroke Recovery
  • Neurotechnology And Brain-Computer Interfaces
  • Neurovascular Inflammation
  • Parkinson?s Disease And Movement Disorders
  • Pediatric Neurology
  • Pediatric Stroke
  • Post-Stroke Cognitive Impairment
  • Precision Neurology And Personalized Medicine
  • Regenerative Neurology
  • Robotic And Technology-Assisted Rehabilitation
  • Sleep Disorders And Neurological Health
  • Speech And Language Rehabilitation
  • Spinal Cord Injury And Neurological Disorders
  • Stem Cell Therapy In Neurological Disorders
  • Stroke Prevention And Risk Management
  • Thrombolytic Therapy
  • Transient Ischemic Attack
  • Traumatic Brain Injury
  • Virtual Reality In Neurorehabilitation